| 4LGK | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | AU, CL | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | The mode of action of anticancer gold-based drugs: a structural perspective., Messori L, Scaletti F, Massai L, Cinellu MA, Gabbiani C, Vergara A, Merlino A, Chem Commun (Camb). 2013 Sep 18. PMID:24045294 | ||||||||||||||
| Data retrieval |
![]() |
| View 4LGK in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |